Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial (2016)

First Author: McAllister-Williams R
Attributed to:  Antiglucocorticoid augmentation of antiDepressants in Depression (The ADD study) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2215-0366(15)00436-8

PubMed Identifier: 26727041

Publication URI: http://europepmc.org/abstract/MED/26727041

Type: Journal Article/Review

Parent Publication: The Lancet Psychiatry

Issue: 2

ISSN: 2215-0366